Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.

Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Bumbasirevic U, Vukovic I, Dragicevic D, Tulic C.

BJU Int. 2012 Apr;109(7):1037-42. doi: 10.1111/j.1464-410X.2011.10461.x.

2.

Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.

Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.

Urology. 2010 Feb;75(2):328-32. doi: 10.1016/j.urology.2009.07.1350.

PMID:
20018349
3.

Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.

Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M; French Collaborative National Database on U.U.T.-U.C..

BJU Int. 2012 Oct;110(8):1134-41. doi: 10.1111/j.1464-410X.2012.10960.x.

4.

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.

BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x.

5.

Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?

Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF.

BJU Int. 2006 Dec;98(6):1176-80.

6.
7.

Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.

Novara G, De Marco V, Dalpiaz O, Galfano A, Bouygues V, Gardiman M, Martignoni G, Patard JJ, Artibani W, Ficarra V.

Int J Urol. 2009 Feb;16(2):187-91. doi: 10.1111/j.1442-2042.2008.02201.x.

8.

Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.

Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguié M, Ruffion A, Rouprêt M; French Collaborative National Database on UUT-UC..

Eur Urol. 2011 Dec;60(6):1258-65. doi: 10.1016/j.eururo.2011.05.049.

PMID:
21665356
9.

Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival.

Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Dragicevic D, Bumbasirevic U, Tulic C.

Int Urol Nephrol. 2011 Sep;43(3):729-35. doi: 10.1007/s11255-011-9902-4.

PMID:
21350863
10.

Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.

Roscigno M, Cozzarini C, Bertini R, Scattoni V, Freschi M, Da Pozzo LF, Briganti A, Gallina A, Capitanio U, Colombo R, Giorgio G, Montorsi F, Rigatti P.

Eur Urol. 2008 Apr;53(4):794-802. doi: 10.1016/j.eururo.2008.01.008.

PMID:
18207313
11.

Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.

Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

Eur J Cancer. 2009 Dec;45(18):3291-7. doi: 10.1016/j.ejca.2009.06.016.

PMID:
19615885
12.

The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.

Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, Bochner BH, Coleman J, Dalbagni G.

Eur Urol. 2010 Oct;58(4):574-80. doi: 10.1016/j.eururo.2010.07.003.

13.

The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract.

Park S, Hong B, Kim CS, Ahn H.

J Urol. 2004 Feb;171(2 Pt 1):621-5.

PMID:
14713773
14.

The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.

Waldert M, Remzi M, Klingler HC, Mueller L, Marberger M.

BJU Int. 2009 Jan;103(1):66-70. doi: 10.1111/j.1464-410X.2008.07950.x.

15.

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG.

Urology. 1998 Oct;52(4):594-601.

PMID:
9763077
16.

Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours.

Bin X, Roy OP, Ghiraldi E, Manglik N, Liang T, Vira M, Kavoussi LR.

BJU Int. 2012 Dec;110(11 Pt B):E514-9. doi: 10.1111/j.1464-410X.2012.11199.x.

17.

Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.

Novara G, De Marco V, Gottardo F, Dalpiaz O, Bouygues V, Galfano A, Martignoni G, Patard JJ, Artibani W, Ficarra V.

Cancer. 2007 Oct 15;110(8):1715-22.

18.

Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review.

Rai BP, Shelley M, Coles B, Somani B, Nabi G.

BJU Int. 2012 Nov;110(10):1426-35. doi: 10.1111/j.1464-410X.2012.11341.x. Review.

19.

Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.

Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF.

BJU Int. 2011 Aug;108(3):406-12. doi: 10.1111/j.1464-410X.2010.09826.x.

20.

Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival.

Lehmann J, Suttmann H, Kovac I, Hack M, Kamradt J, Siemer S, Wullich B, Zwergel U, Stöckle M.

Eur Urol. 2007 May;51(5):1281-8.

PMID:
17125909
Items per page

Supplemental Content

Support Center